← ANALYST RATINGS · TIPRANKS
Establishment Labs Holdings (ESTA): analyst forecast and price target
Analyst consensus
Strong Buy5 Buy0 Hold0 Sell
Ratings of 5 analysts in the last 3 months · top analysts only12-month forecast
Based on 5 price targets given in the last 3 months, the average target is $99.40, the highest $117, the lowest $85.00. The average is +68.0% from the last price of $59.18.
Analyst ratings 10
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $59.00 → $58.00−1.7% | Hold | −2.0% | Reiterated | 16.10.26on TipRanks Oct 15 23:05 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $57.00 → $55.00−3.5% | Sell | −7.1% | Downgrade | 16.10.26on TipRanks Oct 15 23:05 | — | |
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $58.00 → $57.00−1.7% | Hold | −3.7% | Reiterated | 16.10.26on TipRanks Oct 15 23:05 | — | |
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $58.00 → $56.00−3.4% | Hold | −5.4% | Reiterated | 16.10.26on TipRanks Oct 15 23:05 | — | |
| Michael Matson★★★★★★★★★★#1853 · hits 50% · avg +6.0% | Needham | $95.00 | Buy | +60.5% | Reiterated | 15.10.26on TipRanks 07:30 | +5.7%next day −2.4% | ↗ |
| AI xAi Medical - DevicesxAI Grok-3 | TipRanks - xAI | $62.00 → $58.00−6.5% | Hold | −2.0% | Reiterated | 15.10.26on TipRanks 00:05 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $59.00 → $56.00−5.1% | Hold | −5.4% | Reiterated | 15.10.26on TipRanks 00:05 | — | |
| Jonathan Block★★★★★★★★★★#2320 · hits 50% · avg +5.3% | Stifel Nicolaus | $85.00 | Buy | +43.6% | Initiated | 14.10.26on TipRanks 17:15 | +5.7%next day −2.4% | ↗ |
| Caitlin Roberts★★★★★★★★★★#1832 · hits 65% · avg +14.7% | Canaccord Genuity | $105 | Buy | +77.4% | Reiterated | 06.10.26on TipRanks 06:50 | −2.3%next day −2.0% · 5 days −10.3% | ↗ |
| Sam Eiber★★★★★★★★★★#4161 · hits 53% · avg +8.6% | BTIG | $103 | Buy | +74.0% | Reiterated | 05.10.26on TipRanks Oct 6 05:55 | +3.1%next day −2.3% · 5 days −7.7% | ↗ |
| Josh Jennings★★★★★★★★★★#3537 · hits 46% · avg +3.0% | TD Cowen | $117 | Buy | +97.7% | Reiterated | 05.10.26on TipRanks Oct 6 05:30 | +3.1%next day −2.3% · 5 days −7.7% | ↗ |
| Matthew Taylor★★★★★★★★★★#1367 · hits 55% · avg +7.2% | Jefferies | $105 | Buy | +77.4% | Reiterated | 08.09.26on TipRanks 09:07 | +1.9%next day −0.6% · 5 days −3.9% | ↗ |
| Joanne Wuensch★★★★★★★★★★#3684 · hits 55% · avg +2.3% | Citi | $92.00 | Buy | +55.5% | Upgrade | 13.08.26on TipRanks 11:45 | −0.7%next day +5.3% · 5 days −3.4% | ↗ |
| Allen Gong★★★★★★★★★★#2251 · hits 46% · avg +14.7% | J.P. Morgan | $95.00 | Buy | +60.5% | Reiterated | 10.08.26on TipRanks Aug 11 08:07 | −3.0%next day −0.7% · 5 days +2.1% | ↗ |
| Anthony Petrone★★★★★★★★★★#1225 · hits 54% · avg +8.5% | Mizuho Securities | $100 → $105+5.0% | Buy | +77.4% | Reiterated | 15.07.26on TipRanks 07:54 | +4.3%next day +2.4% · 5 days +4.6% | ↗ |
| Mason Carrico★★★★★★★★★★#10833 · hits 38% · avg −4.7% | Stephens | $90.00 | Buy | +52.1% | Assigned | 25.02.26on TipRanks 08:15 | −2.6%next day −0.9% · 5 days −8.0% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Establishment Labs Holdings
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $102 at a price of $64.17 (+59.1%); now: $99.62 at $59.18 (+68.3%).
PriceAverage targetTop analysts’ target
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 0 | 0 | 2 | 4 |
| Buy | 5 | 8 | 7 | 8 | 6 | 6 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 10.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $-0.26 (from $-0.32 to $-0.20). Last quarter: $-0.39.
Sales
Next quarter’s sales estimate — $67M (from $65M to $68M). Last quarter: $68M.
Best top-analyst consensus in the sector · Healthcare
About Establishment Labs Holdings
- CEO: Fillipo Peter Caldini
- Employees: 1,004
- 11401 century oaks terrace, Austin, TX, 78758, US
- www.establishmentlabs.com
Establishment Labs Holdings Inc. operates as a medical technology enterprise specializing in the creation and commercialization of devices for aesthetic and reconstructive plastic surgery. The company is primarily recognized for its silicone gel-filled breast implants, sold under the Motiva Implants brand. Among these are the Motiva Ergonomix and Motiva Ergonomix2, which are distinctive, gravity-sensitive, round, soft silicone-gel-filled implants. Furthermore, Establishment Labs provides the Motiva Flora Tissue Expander for breast tissue and distributes the Puregraft range of products, utilized for the harvesting and redistribution of autologous adipose tissue. The firm markets its offerings across Europe, Latin America, the Asia-Pacific region, and other global markets, leveraging both a direct sales force and exclusive distributors. Founded in 2004, Establishment Labs has its main office situated in Alajuela, Costa Rica.
Data from the stock’s TipRanks forecast page, read 22 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗